Back to News
Market Impact: 0.2
CoreAge Rx Cuts GLP-1 Prices to as Low as $79 a Month
Source: PR Newswire
Healthcare & BiotechConsumer Demand & RetailCompany Fundamentals
CoreAge Rx announced annual-payment pricing of $79 per month for compounded semaglutide and $129 per month for compounded tirzepatide. The semaglutide price is down from $99 per month; the article excerpt does not specify a prior tirzepatide price.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- GIC Private Ltd, Medline 10% owner, sells over $721m in shares
- A 32% beat, a +6% jump: the IT solutions name our models picked in July
- Nvidia Is on the Verge of a $6 Trillion Market Value
- Controversial $110 billion mega-merger of Paramount and Warner Bros. finally closes
- What Marvell's rosy long-term guidance means for our AI chip stocks
- Analysis-Vietnam’s banks tap investors for $7 billion as economy runs red hot